Effect of Tocilizumab in Mortality among Patients with Severe and Critical Covid-19: Experience in a Third-Level Medical Center

• Main Authors: Bernardo A. Martinez-Guerra (Author), Nereyda A. de- (Author), Karla M. Tamez-Torres (Author), Carla M. Román-Montes (Author), Sandra Rajme-López (Author), Edgar Ortiz-Brizuela (Author), Carlos A. Aguilar-Salinas (Author), Juan Sierra-Madero (Author), José Sifuentes-Osornio (Author), Alfredo Ponce- (Author), María F. González-Lara (Author)
• Format: Book
• Published: Permanyer, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Trials evaluating safety and efficacy of tocilizumab in coronavirus disease 19 (COVID-19) show contradictory results. Objective: The objective of the study was to evaluate the effect of tocilizumab in hospital mortality among patients with severe COVID-19 in a third-level medical center....